Greetings from Freyr China

Freyr is a leading Regulatory solutions provider offering comprehensive services to life sciences firms across the regulatory spectrum. With a robust presence spanning over 120 countries, we facilitate the "local to Global" journey for life sciences companies.

In China, Freyr China plays a pivotal role in assisting companies with Drug registration in China under the National Medical Products Administration (NMPA). Our services encompass Regulatory Strategy formulation, Market Intelligence, In-country representation, Post-Market Surveillance (PMS) functions, and more. Additionally, we provide cutting-edge Regulatory software solutions tailored to streamline the entire NMPA registration life cycle covering everything from the China new drug approval process to China generic drug approval process.

• Global Presence in 
  25+ Countries
• 2100+ 
  Inhouse Regulatory 
  Experts & Growing
• Support in 
  120+ Countries
• 1750+ Global 
  clients & growing